ADVERTISEMENT
LATEST
View allClinical Summary
Newer T2D drugs offer CV risk reduction in older patients
Clinical Summary
CLL: pirtobrutinib shows promise in phase 2
March Challenge
Ends in 8d 8h
3 PTS
intermediate
Neutralizing antibody combo and COVID-19 events
3 PTS
intermediate
Arthritis drugs for severe COVID-19
3 PTS
intermediate
Alcohol consumption and Afib risk
3 PTS
intermediate
Afib mortality in Europe
4 PTS
expert
Global Ebola vaccine stockpile
3 PTS
intermediate
Hypothyroidism treatment and breast cancer risk
2 PTS
intermediate
Maternal autoimmune disease and ADHD risk
3 PTS
intermediate
Single-dose COVID-19 vaccine
4 PTS
expert
Tralokinumab for inflammatory skin condition
Conferences
Topic Challenges
Quiz challenge Emerging diseases: COVID-19
Closed
10 Questions Available
Ends on 1 October 2020
ESMO 2020 topic challenge
Open
5 Questions Available
Ends in 28d 4h
Women's health challenge
Open
10 Questions Available
Ends in 1m 19d 4h
Antibiotics - Consequence of MDR carriage
Open
6 Questions Available
Ends in 1m 19d 4h
Neurological disorders challenge
Open
10 Questions Available
Ends in 2m 19d 4h
Rheumatology challenge
Open
10 Questions Available
Ends in 3m 19d 4h
Mental health challenge
Open
10 Questions Available
Ends in 4m 19d 4h
Lyme Disease
Open
11 Questions Available
Ends in 5m 19d 4h
Topic challenge - Children conditions
Open
7 Questions Available
Ends in 5m 19d 4h
More News
ADVERTISEMENT
